Senvest Capital Inc. Stock

Equities

SEC

CA81731L1094

Investment Management & Fund Operators

Market Closed - Toronto S.E. 11:00:00 2024-04-16 am EDT 5-day change 1st Jan Change
285 CAD 0.00% Intraday chart for Senvest Capital Inc. 0.00% -8.06%
Sales 2022 -740M -535M Sales 2023 427M 309M Capitalization 766M 554M
Net income 2022 -326M -236M Net income 2023 83M 60.02M EV / Sales 2022 4.28 x
Net cash position 2022 3.97B 2.87B Net cash position 2023 3.43B 2.48B EV / Sales 2023 -6.24 x
P/E ratio 2022
-2.47 x
P/E ratio 2023
9.18 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 39.47%
More Fundamentals * Assessed data
Dynamic Chart
North American Morning Briefing : Focus Turns to -2- DJ
Biolinq Incorporated announced that it has received $58 million in funding from a group of investors CI
Senvest Capital Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Senvest Capital Brief: Reporting net income attributable to common shareholders of $83.6 million or $33.78 per share for year ended December 31, 2023 MT
Biolinq Incorporated announced that it expects to receive funding CI
Tranche Update on Senvest Capital Inc.'s Equity Buyback Plan announced on August 11, 2022. CI
Tranche Update on Senvest Capital Inc.'s Equity Buyback Plan announced on August 11, 2023. CI
Senvest Capital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Senvest Capital Brief: Reported net loss attributable to common shareholders of ($67.0) million or ($27.07) per share for Q3 MT
Senvest Capital Inc.'s Equity Buyback announced on August 11, 2022, has expired with 13,000 shares, representing 0.52% for CAD 3.96 million. CI
Senvest Capital Obtains TSX Consent For Normal Course Issuer Bid MT
Senvest Capital Inc. announces an Equity Buyback for 100,000 shares, representing 4.04% of its issued share capital. CI
Senvest Capital Brief: Announcing Acceptance by TSX of Normal Course Issuer Bid MT
Senvest Capital Inc. authorizes a Buyback Plan. CI
Senvest Capital Brief: Reporting Q2 Diluted earnings (loss) per share attributable to common shareholders of $8.58 MT
More news
1 month-3.18%
3 months-8.06%
6 months-4.90%
Current year-8.06%
More quotes
1 month
280.01
Extreme 280.01
298.00
Current year
280.01
Extreme 280.01
325.00
1 year
280.00
Extreme 280
327.51
3 years
279.00
Extreme 279
420.00
5 years
0.00
Extreme 0
420.00
10 years
0.00
Extreme 0
420.00
More quotes
Managers TitleAgeSince
Director of Finance/CFO - -
Chairman - 68-11-19
Director/Board Member - 71-12-31
Members of the board TitleAgeSince
Chairman - 68-11-19
Director/Board Member - 00-12-31
Director/Board Member - 14-06-05
More insiders
Date Price Change Volume
24-04-16 285 0.00% 0
24-04-15 - +-NaN% 30
24-04-11 - +-NaN% 78
24-04-09 - +-NaN% 10

Delayed Quote Toronto S.E., April 16, 2024 at 11:00 am EDT

More quotes
Senvest Capital Inc. is a Canada-based holding company with interests in investment management and direct investing in public securities and private investments. The Company and its subsidiaries hold investments in equity and real estate holdings that are located predominantly in the United States. The Company's subsidiaries include Senvest Global (KY) L.P., Senvest Global L.P., RIMA Senvest Master Fund GP, L.L.C., Argentina Capital Inc., Pennsylvania Properties Inc., Senvest Technology Partners GP, L.L.C, Senvest Master Fund, L.P., Senvest Technology Partners Master Fund, L.P., and Senvest Cyprus Recovery Investment Fund, L.P.
More about the company